Joel Greenblatt's MEDP Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 16,676 shares of Medpace Holdings, Inc. (MEDP) worth $8.57 M, representing 0.04% of the portfolio. First purchased in 2017-Q4, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 151,528 shares. Largest reduction occurred in Q2 2020, reducing 34,898 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2017 | +9,789 | New Buy | 9,789 | $36.27 |
| Q1 2018 | -9,789 | Sold Out | 0 | $0.00 |
| Q4 2018 | +151,528 | New Buy | 151,528 | $52.93 |
| Q1 2019 | -14,978 | Reduce 9.88% | 136,550 | $58.97 |
| Q2 2019 | -5,658 | Reduce 4.14% | 130,892 | $65.42 |
| Q3 2019 | -21,533 | Reduce 16.45% | 109,359 | $84.04 |
| Q4 2019 | -23,424 | Reduce 21.42% | 85,935 | $84.06 |
| Q1 2020 | -31,435 | Reduce 36.58% | 54,500 | $73.38 |
| Q2 2020 | -34,898 | Reduce 64.03% | 19,602 | $93.00 |
| Q3 2020 | -9,093 | Reduce 46.39% | 10,509 | $111.71 |
| Q4 2020 | -1,562 | Reduce 14.86% | 8,947 | $139.15 |
| Q1 2021 | -526 | Reduce 5.88% | 8,421 | $163.99 |
| Q2 2021 | -341 | Reduce 4.05% | 8,080 | $176.61 |
| Q3 2021 | -186 | Reduce 2.30% | 7,894 | $189.26 |
| Q4 2021 | -1 | Reduce 0.01% | 7,893 | $217.66 |
| Q1 2022 | -262 | Reduce 3.32% | 7,631 | $163.54 |
| Q2 2022 | +1,682 | Add 22.04% | 9,313 | $149.68 |
| Q3 2022 | +371 | Add 3.98% | 9,684 | $157.17 |
| Q4 2022 | -1,567 | Reduce 16.18% | 8,117 | $212.41 |
| Q1 2023 | +6,764 | Add 83.33% | 14,881 | $188.05 |
| Q2 2023 | -6,751 | Reduce 45.37% | 8,130 | $240.17 |
| Q3 2023 | -1,000 | Reduce 12.30% | 7,130 | $242.13 |
| Q4 2023 | -143 | Reduce 2.01% | 6,987 | $306.53 |
| Q1 2024 | -1,008 | Reduce 14.43% | 5,979 | $404.15 |
| Q2 2024 | -96 | Reduce 1.61% | 5,883 | $411.85 |
| Q3 2024 | +2,327 | Add 39.55% | 8,210 | $333.80 |
| Q4 2024 | -2,457 | Reduce 29.93% | 5,753 | $332.23 |
| Q1 2025 | +1,101 | Add 19.14% | 6,854 | $304.69 |
| Q2 2025 | +7,522 | Add 109.75% | 14,376 | $313.86 |
| Q3 2025 | +2,300 | Add 16.00% | 16,676 | $514.16 |
Joel Greenblatt's Medpace Holdings Investment FAQs
Joel Greenblatt first purchased Medpace Holdings, Inc. (MEDP) in Q4 2017, acquiring 9,789 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Medpace Holdings, Inc. (MEDP) for 30 quarters since Q4 2017.
Joel Greenblatt's largest addition to Medpace Holdings, Inc. (MEDP) was in Q4 2018, adding 151,528 shares worth $8.02 M.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 16,676 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $8.57 M.
As of the Q3 2025 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Medpace Holdings, Inc. (MEDP) was 151,528 shares, as reported at the end of Q4 2018.